Business Context and Reporting Period
This Form 8-K Current Report was filed by Prestige Brands Holdings, Inc. on June 1, 2016, covering an event that occurred on May 26, 2016. The filing addresses corporate governance changes rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the announcement of a new Board of Directors member.
Material Changes
The primary material change reported is the election of Natale S. Ricciardi to the Company's Board of Directors. This appointment increases the Board size to six independent directors, a move attributed by management to the Company's dramatic growth in recent years.
Management Commentary and Outlook
Lead Director Gary E. Costley stated that Mr. Ricciardi's 39-year career at Pfizer, including his role as President of Pfizer Global Manufacturing, adds valuable expertise in pharmaceutical operations and manufacturing. Management expects this addition to help the Company continue its strong momentum. No specific financial guidance or risk factors were disclosed in this filing.
Investor Verification Checklist
- Verify the effective date of Natale S. Ricciardi's board membership.
- Confirm the total number of directors on the Board following this appointment.
- Review Mr. Ricciardi's existing board affiliations (Asterias Biotherapeutics, Inc. and Dynavax Technologies Corporation) for potential conflicts of interest.
- Check subsequent filings for any compensatory arrangements related to this new director appointment.